Stocks and Investing
Stocks and Investing
Wed, November 11, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, November 10, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Paul Knight Initiated (BLFS) at Buy and Held Target at $40 on, Nov 10th, 2020
Paul Knight of Keybanc, Initiated "BioLife Solutions, Inc." (BLFS) at Buy and Held Target at $40 on, Nov 10th, 2020.
Paul has made no other calls on BLFS in the last 4 months.
There are 3 other peers that have a rating on BLFS. Out of the 3 peers that are also analyzing BLFS, 2 agree with Paul's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Suraj Kalia of "Oppenheimer" Downgraded from Buy to Hold on, Tuesday, September 22nd, 2020
- Robert Wasserman of "Benchmark" Downgraded from Strong Buy to Hold on, Tuesday, August 11th, 2020
This is the rating of the analyst that currently disagrees with Paul
- Chris Li of "Cowen & Co." Initiated at Buy and Held Target at $33 on, Friday, September 18th, 2020
Contributing Sources